AMH and Infertility: Anti-mullerian hormone (AMH), now suggested as the best indirect measures of ovarian reserve [1], has different implications in clinical practice, from diagnosis of women with polycystic ovarian syndrome (PCOS) or those with diminished ovarian reserve to prediction of infertility treatment success rates and time to menopause [2–4].